Report #2870637

Received Nov 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 0.2 yrs
State: MN
Recovered: Unknown
Vaccinated: Oct 23, 2025
Onset: Oct 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Z007870	—

Symptoms (2)

No adverse eventWrong product administered

Symptom narrative

No additional AE; children were supposed to receive their first dose of VAXNEUVANCE and the CAPVAXIVE was inadvertently administered; This spontaneous report was received from a Nurse and refers to a 2-month-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-Oct-2025, the patient was inadvertently vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #Z007870, expiration date: 23-Oct-2026), (dose, route of administration and anatomical site were not reported) as prophylaxis, she was supposed to receive her first dose of Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) as prophylaxis and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was inadvertently administered (Wrong product administered). No adverse event. Batch/Lot number is being requested and will be submitted if received. This is one of two reports from the same source.